Merck

CFOs On the Move: Week Ending March 26
CFOs On the Move: Week Ending February 5
Merck Drops Out of COVID-19 Vaccine Race
Merck Buys OncoImmune in COVID Treatment Move
Merck Enters Race to Develop COVID Vaccine
Merck, Sanofi in Deals for Cancer Drug Firms
Merck Goes Hostile in Versum Takeover Battle
Bayer to Shed Assets, Cut Jobs Amid Share Pressure
P&G Buys Merck Unit to Boost OTC Business
Data Held Hostage
Quantifying Cyber Risks
Merck Buys Cough Drug Developer for $1.25B
Ex-Merck Analyst Hit with Insider Trading Rap
CFOs on the Move: Week Ended March 28
Transforming Cisco: One Finance Function At a Time